Neostigmine methylsulfate
- Product NDC
- 70700-171
- 11-digit product format
- 707000171
- Labeler code
- 70700
- Product ID
- 70700-171_8649cf31-5ecf-2048-5bf0-1b6e84f190f4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Neostigmine methylsulfate
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Xiromed LLC
- Application
- ANDA212968
- Marketing category
- ANDA
- Marketing start
- 2020-09-09
- Substance
- NEOSTIGMINE METHYLSULFATE
- Active strength
- .5 mg/mL
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Neostigmine methylsulfate
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| NEOSTIGMINE METHYLSULFATE | .5 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 98IMH7M386 |
| Rxcui | 311935, 311936 |
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70700-171 | NEOSTIGMINE METHYLSULFATE INJECTION [XIROMED LLC] | 6 | Current NDC, Legacy NDC | 20250112_801225d9-eb71-dbef-e860-4caf7a22f27f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70700-171-22 | 70700017122 | 1 VIAL, MULTI-DOSE in 1 CARTON (70700-171-22) / 10 mL in 1 VIAL, MULTI-DOSE | 2020-09-09 | 0000-00-00 | No | No | Current |
| 70700-171-23 | 70700017123 | 10 VIAL, MULTI-DOSE in 1 CARTON (70700-171-23) / 10 mL in 1 VIAL, MULTI-DOSE | 2020-09-09 | 0000-00-00 | No | No | Current |